if approved, at least $42 pps, prob more... When Elan announced it was paying THRX a one billion dollar royalty payment for its copd drug portfolio, it reached $42...If CRL, (highly unlikely) prob mid 30's...But remember there was not even an FDA advisory panel meeting for Anoro...I am looking forward to Dec 18. Maybe even a GSK buyout soon thereafter for at least $70 pps...As my good friend neurodragon says, "Dom times are soon ahead"!!!! And to quote the stock guru Siamese Kitty.."Kaboom"!!!!!
Sentiment: Strong Buy
doubt the earnings will be a big deal.. Look for the guidance and conference call to move the prive in a favorable direction.